Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jan 7, 2017; 23(1): 110-120
Published online Jan 7, 2017. doi: 10.3748/wjg.v23.i1.110
Table 1 TFF1, TFF3, and TWIST1 expression in different colorectal cancer tissues n (%)
HistologynTFF1
TFF3
TWIST1
-++++++-++++++-++++++
CRC7525 (41)19 (35.8)23 (67.6)8 (57.1)16 (72.7)34 (55.7)21 (38.9)4 (16)34 (34.7)18 (56.3)16 (64)7 (100)
MNT4734 (55.7)12 (22.6)1 (2.9)008 (13.1)22 (40.7)17 (68)39 (41.9)7 (21.9)1 (4.3)0
MLN302 (3.3)17 (32.1)8 (23.5)3 (21.4)6 (27.3)14 (23)8 (14.8)2 (8)20 (21.7)5 (15.6)5 (21.7)0
Liver M1005 (9.4)2 (5.9)3 (21.4)05 (8.2)3 (5.6)2 (8.0)5 (5.4)2 (6.3)3 (13)0
OverallP = 0.000P = 0.000P = 0.000
Table 2 Comparison between low and high expression of TFF1, TFF3, and TWIST1 in different colorectal cancer tissues n (%)
HistologynTFF1
TFF3
TWIST1
LowHighP valueLowHighP valueLowHighP value
CRC7544 (38.6)31 (64.6)0.00050 (60.2)25 (31.6)0.00052 (40)23 (71.9)0.001
MNT4746 (40.4)1 (2.1)0.0008 (9.6)39 (49.4)0.00046 (35.4)1 (3.1)0.0001
MLN3019 (16.7)11 (22.9)0.65920 (24.1)10 (12.7)0.81825 (19.2)5 (15.6)0.142
Liver M105 (4.4)5 (10.4)0.6025 (6)5 (6.3)0.4947 (5.4)3 (9.4)0.966
Table 3 Correlation among TFF1, TFF3 and TWIST1expression n (%)
Protein expressionTFF1
TFF3
LowHighP valueLowHighP value
TWIST10.2970.623
Low32 (72.7)19 (61.3)31 (66)20 (71.4)
High12 (27.3)12 (38.7)16 (34)8 (28.6)
TFF3
Low22 (46.8)25 (53.2)0.007
High22 (78.6)6 (21.4)
Table 4 Correlation between TFF1, TFF3, and TWIST1 expression and clinicopathological Characteristics of colorectal cancers n (%)
Characteristicn = 75TFF1
TFF3
TWIST1
LowHighP valueLowHighP valueLowHighP value
Age (yr)0.2990.3680.840
≤ 6028 (63.6)17 (54.8)27 (57.4)18 (64.3)31 (60.8)14 (58.3)
> 6016 (36.4)14 (45.2)20 (42.6)10 (35.7)20 (39.2)10 (41.7)
Gender0.3690.1460.134
Male30 (68.2)18 (58.1)33 (70.2)15 (53.6)30 (58.8)18 (75.0)
Female14 (31.8)13 (41.9)14 (29.8)13 (46.4)21 (41.2)6 (25.0)
Histology0.0890.4750.397
Adenocarcinoma42 (95.5)26 (83.9)42 (89.4)26 (92.9)47 (92.2)21 (87.5)
Mucinous2 (4.5)5 (16.1)5 (10.6)2 (7.1)4 (7.8)3 (12.5)
Differentiation0.0290.1360.234
Well10 (22.7)12 (38.7)15 (31.9)7 (25.0)18 (35.3)4 (16.7)
Moderate16 (36.4)15 (48.4)22 (46.8)9 (32.1)20 (39.2)11 (45.8)
Poor18 (40.9)4 (12.9)10 (21.3)12 (42.9)13 (25.5)9 (37.5)
Location0.8020.4110.847
Colon31 (70.5)21 (67.7)31 (66.0)21 (75)35 (68.6)17 (70.8)
Rectum13 (29.5)10 (32.3)16 (34.0)7 (25)16 (31.4)7 (30.7)
T0.5450.6510.246
12 (4.5)01 (2.1)1 (3.6)1 (2.0)1 (4.2)
210 (22.7)9 (29.0)14 (29.8)5 (17.9)16 (31.4)3 (12.5)
313 (29.5)7 (22.6)11 (23.4)9 (32.1)11 (21.6)9 (37.5)
419 (43.2)15 (48.4)21 (44.7)13 (46.4)23 (45.1)11 (45.8)
N0.1430.0340.000
No26 (59.1)13 (41.9)20 (42.6)19 (67.9)34 (66.7)5 (20.8)
Yes18 (40.9)18 (58.1)27 (57.4)9 (32.1)17 (33.3)19 (79.2)
M0.4840.2670.288
No41 (93.2)28 (90.3)42 (89.4)27 (96.4)48 (94.1)21 (87.5)
Yes3 (6.8)3 (9.7)5 (10.6)1 (3.6)3 (5.9)3 (12.5)
Staging0.9170.0310.003
I9 (20.5)6 (19.4)11 (23.4)4 (14.3)13 (25.5)2 (8.3)
II17 (38.6)10 (32.3)11 (23.4)16 (57.1)23 (45.1)4 (16.7)
III15 (34.1)12 (38.7)20 (42.6)7 (25.0)12 (23.5)15 (62.5)
IV3 (6.8)3 (9.7)5 (10.6)1 (3.6)3 (5.9)3 (12.5)
Table 5 Significant predictive factors for cancer-specific survival in COX proportional-hazard analysis
Prognostic factorUnivariate HR (95%CI)P valueMultivariate HR (95%CI)P value
Age0.404 (0.189-0.864)0.0190.262 (0.106-0.647)0.004
Gender1.137 (0.565-2.287)0.7191.065 (0.450-2.519)0.887
Histopathological type0.526 (0.126-2.193)0.3780.380 (0.080-1.809)0.224
Tumor differentiation0.939 (0.611-1.445)0.7750.701 (0.395-1.246)0.226
T1.556 (1.030-2.350)0.0360.979 (0.578-1.657)0.937
N2.961 (1.954-4.485)0.0001.668 (0.716-3.889)0.236
M12.519 (4.593-34.120)0.0002.728 (0.672-11.064)0.160
Stage4.507 (2.706-7.507)0.0002.718 (1.003-7.368)0.039
TFF11.805 (0.929-3.509)0.0811.539 (0.661-3.579)0.317
TFF30.382 (0.178-0.819)0.0130.224 (0.085-0.593)0.003
TWIST12.819 (1.441-5.515)0.0021.904 (0.847-4.278)0.119